Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYFEFACY: Medical vs Surgical Management of Arrested Pregnancy
NCT05049980Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Nov 2021
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of mifepristone and misoprostol in early pregnancy loss (EPL) (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Number of participants with treatment-related adverse events at Day 0 and Patient satisfaction at Day 0. Started Nov 2021; status: completed.
02
Drugs
mifepristonemisoprostol
03
Conditions
early pregnancy loss (EPL)
Beyond the preview
Go deeper on NCT05049980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05049980.